Shares of Novavax Inc. NVAX, +6.57% advanced 6.57% to $57.46 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index COMP, -0.16% falling 0.16% to 12,348.76 and Dow Jones Industrial Average DJIA, -1.23% falling 1.23% to 32,396.17. The stock’s rise snapped a two-day losing streak. Novavax Inc. closed $220.34 short of its 52-week high ($277.80), which the company reached on September 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Replimune Group Inc. REPL, +6.66% rose 6.66% to $20.03, VBI Vaccines Inc. VBIV, +3.52% rose 3.52% to $0.83, and AnaptysBio Inc. ANAB, -0.30% fell 0.30% to $20.22. Trading volume (4.5 M) remained 3.1 million below its 50-day average volume of 7.6 M.